Skip to content

Strategy Research for Bu-Shen Hua-Yu Integrative Medicine of cerebral small vessel disease

Strategy Research for Bu-Shen Hua-Yu Integrative Medicine of cerebral small vessel disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018723
Enrollment
Unknown
Registered
2018-10-06
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral small vessel disease

Interventions

Group 1:tonifying kidney and removing blood stasis
Group 2:Placebo

Sponsors

Shanghai 6th People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. clinical manifestations: asymptomatic lacunar infarction, CMB and partial leukoaraiosis, various lacunar syndrome and vascular cognitive dysfunction; imaging findings: lacunar infarction (LI) or lacunar (lacune) Or white matter lesions (WML) or perivascular space enlargement or cerebral microbleeds (CMB); 2. no major cerebral vascular disease or intracranial tumor by skull MRI; 3. aged 50 to 80 years old; 4. MoCA scale = 26 points; MES scale = 75 points 5 subjects volunteered to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. There are other cerebral small vessel diseases such as amyloid angiopathy; other hereditary disease-related small vessel diseases (such as CADSIL, FABRY disease, etc.), inflammation and immune-mediated VCSV and vasculitis, other small venous collagen diseases History of vascular disease; severe arrhythmia such as atrial fibrillation, stroke caused by Parkinson's disease, macrovascular disease, cardiogenic stroke, exclude other diseases that affect intelligence; 2. severe liver and kidney dysfunction; 3. allergic constitution Or those who are allergic to multiple drugs; 4. those with other serious diseases, such as malignant tumors, severe malnutrition, mental disorders, etc.; 5. exclude large vessel disease.

Design outcomes

Primary

MeasureTime frame
MoCA;MES;skull MRI;

Secondary

MeasureTime frame
Ambulatory blood pressure monitoring;TC;TG;LDL;HDL;HbAIC;

Countries

China

Contacts

Public ContactQingping Huo

Shanghai 6th People's Hospital

huoqingping005@163.com+86 18930177477

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026